Trial intelligence / Profile preview

Visanne in endometriosis

NCT00225199Phase 3Completed

Sponsor
Bayer
Start
Mar 2004
Modality
Small Molecules
01

Overview

A Phase 3 trial of dienogest in endometriosis, sponsored by Bayer. Started Mar 2004; status: completed.

02

Drugs

dienogest
03

Conditions

endometriosis

Beyond the preview

Go deeper on NCT00225199.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00225199.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call